Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
life sciences
national blog main
san francisco blog main
cancer
clinical trials
national top stories
san francisco top stories
cancer drugs
ipo
fda
loxo oncology
national
non-hodgkin lymphoma
novartis
raleigh-durham blog main
raleigh-durham top stories
revolution medicines
roche
san francisco
sanofi
the column group
third rock ventures
venture capital
warp drive bio
2025
abbvie
actavalon
acute myeloid leukemia
ad-comm
affimed
aileron therapeutics
akcea therapeutics
allogene therapeutics
amgen
amicus therapeutics
approval
aprea therapeutics
What
cancer
5
×
ipo
5
×
medicines
research
drug
investors
new
proteins
revolution
targets
therapeutics
allogene
bio
biotech
black
blood
broader
cancer’s
clinic
companies
company
crispr
despite
detect
developing
diamond
disease
diversity
eluded
family
files
firms
frontiers
grail
hardest
hit
hopes
hot
hottest
hunters
Language
unset
Current search:
ipo
×
cancer
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
